New cancer drug shows promise in early human testing
NCT ID NCT03573310
First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 22 times
Summary
This early-stage study tested a new drug called JNJ-64619178 in 114 adults with advanced cancers (like lymphoma, solid tumors, or myelodysplastic syndromes) that had not responded to other treatments. The main goal was to find the safest dose and check for side effects. The drug works by blocking a protein that helps cancer cells grow.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carmel Medical Center
Haifa, 34362, Israel
-
Clinica Univ. de Navarra
Pamplona, 31008, Spain
-
Florida Specialist and Cancer Institute
Sarasota, Florida, 34232, United States
-
Goethe Universität Frankfurt
Frankfurt am Main, 60590, Germany
-
Hadassah Medical Center
Jerusalem, 9112001, Israel
-
Hosp Clinico Univ de Salamanca
Salamanca, 37007, Spain
-
Hosp Univ Fund Jimenez Diaz
Madrid, 28040, Spain
-
Hosp Univ Vall D Hebron
Barcelona, 08035, Spain
-
Hosp. Univ. Germans Trias I Pujol
Badalona, 08916, Spain
-
Hosp. Virgen Del Rocio
Seville, 41013, Spain
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
Princess Margaret Cancer Centre University Health Network
Toronto, Ontario, M5G1Z5, Canada
-
St. Paul's Hospital
Vancouver, British Columbia, V6E 1M7, Canada
-
Tel Aviv Sourasky MC
Tel Aviv, 6423906, Israel
-
Universitaetsklinikum Duesseldorf
Düsseldorf, 40225, Germany
-
Universitaetsklinikum Leipzig
Leipzig, 04103, Germany
-
University of Texas, MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.